scholarly journals A prospective study of adjuvant radiotherapy concomitant with cisplatin followed by paclitaxel carboplatin in high risk early stage endometrial cancer

2016 ◽  
Vol 12 (2) ◽  
pp. 40-46
Author(s):  
Mohamed Mustafa ◽  
Tarek kamel ◽  
Walid Bayoumy ◽  
Mohamed Al kady ◽  
Caroline El maraghi
Keyword(s):  
Endometrial Cancer ◽  
High Risk ◽  
Prospective Study ◽  
Adjuvant Radiotherapy ◽  
Early Stage ◽  
A Prospective Study ◽  
Early Stage Endometrial Cancer

Triple tracer (blue dye, indocyanine green, and Tc99) compared to double tracer (indocyanine green and Tc99) for sentinel lymph node detection in endometrial cancer: a prospective study with random assignment

2019 ◽  
Vol 29 (7) ◽  
pp. 1121-1125 ◽  
Author(s):  
Roy Kessous ◽  
Jeffrey How ◽  
Jeremie Abitbol ◽  
Sanam Puzhakkal ◽  
Liron Kogan ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Indocyanine Green ◽  
Prospective Study ◽  
Early Stage ◽  
Blue Dye ◽  
Detection Rates ◽  
A Prospective Study ◽  
Early Stage Endometrial Cancer

ObjectiveSentinel lymph node (SLN) mapping is increasingly being used in the treatment of apparent early-stage endometrial cancer. The aim of this study was to evaluate whether three tracers (blue dye, indocyanine green (ICG), and technetium-99 (Tc99)) performed better than two (ICG and Tc99).Study DesignProspective study of all consecutive patients (n=163) diagnosed with clinical early-stage endometrial cancer from 2015 to 2017. All patients were randomly assigned to receive a mixture of ICG and Tc99 with or without blue dye. Subgroup analysis for detection rates was performed for each group (double versus triple tracer).ResultsOne hundred and fifty-seven patients met the inclusion criteria. Eighty patients received ICG and Tc99 with unilateral and bilateral SLN detection rates of 97.5% and 81.3%, respectively. Seventy-seven patients received all three tracers with unilateral and bilateral detection rates of 93.5% and 80.5%, respectively. Only one patient in the triple tracer group was detected by blue dye alone. No significant differences were noticed in unilateral or bilateral detection rates between the two groups, nor in the detection of lymph node metastasis.ConclusionThe addition of blue dye to ICG and Tc99 did not demonstrate any improvement in SLN detection.

Defining optimal adjuvant treatment for high-risk early-stage endometrial cancer

2021 ◽  
Vol 162 ◽  
pp. S123-S124
Author(s):  
Olivia Khouri ◽  
Anne Van Arsdale ◽  
Nicole Vilardo ◽  
Divya Gowthaman ◽  
Gregory Gressel ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
High Risk ◽  
Adjuvant Treatment ◽  
Early Stage ◽  
Early Stage Endometrial Cancer

scholarly journals Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high‐risk endometrial cancer: A prospective study

Cancer ◽  
2019 ◽  
Vol 125 (19) ◽  
pp. 3347-3353 ◽  
Author(s):  
Katherine I. Stewart ◽  
Beth Chasen ◽  
William Erwin ◽  
Nicole Fleming ◽  
Shannon N. Westin ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
High Risk ◽  
Prospective Study ◽  
Newly Diagnosed ◽  
Pet Ct ◽  
A Prospective Study

scholarly journals Adjuvant radiotherapy in early stage endometrial cancer

2011 ◽  
Vol 57 (4) ◽  
pp. 431-435
Author(s):  
Antonio Carlos Zuliani ◽  
AureaAkemi Cairo ◽  
Sérgio Carlos Barros Esteves ◽  
Carla Cristina dos Santos Watanabe ◽  
Maércio de OliveiraCunha ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Adjuvant Radiotherapy ◽  
Early Stage ◽  
Early Stage Endometrial Cancer

scholarly journals Adjuvant radiotherapy in early stage endometrial cancer

2011 ◽  
Vol 57 (4) ◽  
pp. 438-442 ◽  
Author(s):  
Antonio Carlos Zuliani ◽  
Aurea Akemi Cairo ◽  
Sérgio Carlos Barros Esteves ◽  
Carla Cristinados Santos Watanabe ◽  
Maércio de Oliveira Cunha ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Adjuvant Radiotherapy ◽  
Early Stage ◽  
Early Stage Endometrial Cancer

Obesity, lymphadenectomy and survival outcomes in intermediate to high-risk, early-stage endometrial cancer patients

2015 ◽  
Vol 11 (4) ◽  
pp. 607-615
Author(s):  
Faina Linkov ◽  
Robert P Edwards ◽  
Andrew Althouse ◽  
Jose A Rauh-Hain ◽  
Marcela G Del Carmen ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
High Risk ◽  
Cancer Patients ◽  
Early Stage ◽  
Survival Outcomes ◽  
Early Stage Endometrial Cancer

Adjuvant therapy for early-stage endometrial cancer: a review

2007 ◽  
Vol 17 (5) ◽  
pp. 949-956 ◽  
Author(s):  
S. Tangjitgamol ◽  
S. Manusirivithaya ◽  
C. Lertbutsayanukul
Keyword(s):  
Radiation Therapy ◽  
Endometrial Cancer ◽  
High Risk ◽  
Adjuvant Therapy ◽  
Adjuvant Treatment ◽  
Hormonal Therapy ◽  
Early Stage ◽  
Favorable Outcome ◽  
Early Stage Endometrial Cancer

Most patients with endometrial cancer (EMC) present their symptoms early in their course, leading to an overall favorable outcome. However, some patients who are in early-stage diseases may carry some risk features that would hamper their prognoses. For these early-stage diseases with high risk of recurrences, radiation therapy certainly plays a major role as an adjuvant treatment. Despite an excellent local diseases control by radiation, systemic failures are still encountered. To improve the prognoses, other types of adjuvant therapy have been attempted. In this review, various options of adjuvant treatment for this early-stage EMC including radiation therapy, chemotherapy, and hormonal therapy are discussed.

The utility of preoperative PET/CT in the detection of extrauterine disease in high-risk endometrial cancer: A prospective study

2018 ◽  
Vol 149 ◽  
pp. 32
Author(s):  
K.I. Stewart ◽  
B. Chasen ◽  
W.D. Erwin ◽  
N.D. Fleming ◽  
S.N. Westin ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
High Risk ◽  
Prospective Study ◽  
Pet Ct ◽  
A Prospective Study
Sign in / Sign up

Export Citation Format

Share Document